Positive context积极背景
Stocks股票 / Health Care / PRGO
Perrigo · Health Care
PRGO US listed · USD美股 · 美元
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of...Perrigo Company plc 是一家美国公司在爱尔兰注册的制造商，生产自有品牌非处方药。尽管Perrigo 70%的净销售额来自美国医疗体系，但其出于税务目的合法将总部设在爱尔兰，该地仅占净销售额的0.60%。
Mid cap中盘 · $2B
Health Care
S&P 600标普600小盘Russell 2000罗素2000
Speculative / unprofitable投机／未盈利
$15.42
+$0.74 · +5.04%
52w low52周低 $8.67high高 $21.81
Extended — wait for a pullback过度拉伸 — 等待回撤
The daily turn is already in — a low formed ~6 days ago at $13.48 and price is back above the 10-day average. What's missing is the weekly timeframe…日线转向已经完成——低点于约 6 天前形成，价位13.48，且价格已重新站上 10 日均线。尚缺的是周线周期的确认，因此这是当下可用的部分信心入场，而非待触发信号：可在此建半仓，或等待周线转向。
As of 2026-09-28截至 2026-09-28
Company intelligence公司情报
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考；使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动，请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Pressure context压力背景
History mode历史模式
Context only仅供参考 · not a signal or recommendation不构成信号或建议
Narrative claims may await line-level citation; verify in the transcript.叙述性内容可能仍待逐行引用，请在电话会原文中核对。
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-09-28
Momentum (RSI 14)动量（RSI 14）
68
Elevated偏高
vs 50-day average相对50日均线
+20.2% above上方
Uptrend intact趋势完好
vs 200-day average相对200日均线
+28.9% above上方
Long trend up长期向上
Volatility波动率
47th percentile第47百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-11-0437
Estimates being raised — 4 analysts预期上调 — 4 位分析师
Beat in 3 of last 4 quarters近 4 季中 3 季超预期
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度（近几个季度） · average平均 18.6%
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | PRGO | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 0.72x | 3.30 | |
| P/S市销率 | 0.50x | 3.19 | |
| Earnings yield盈利收益率 | -67.18% | 2.56 | |
| FCF yield自由现金流收益率 | 6.84% | 4.11 | |
| P/FCF市值/自由现金流 | 14.62x | 21.34 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
$4.3B2025
20202025
5-yr growth5年复合增速 -3.4%
Earnings per share每股收益
$-10.292025
20202025
Free cash flow自由现金流
$145.1M2025
20202025
Gross margin毛利率
35.1%
Operating margin营业利润率
-26.4%
Net margin净利率
-33.5%
FCF margin自由现金流利润率
5.6%
Balance-sheet quality财务体质 4/9
Bankruptcy risk: distress zone破产风险：警戒区
Return on equity股本回报率 -49%
Watch关注
Leverage杠杆
Current ratio流动比率2.76
Capital allocation资本配置
Stock-based comp股权薪酬$54.6M
Share count change (1y)股数变化（1年）+0.8%
Debt coming due到期债务
SEC filingsSEC 文件Debt schedule not loaded yet.到期债务尚未加载。
This panel is still catching up to the SEC filings for this listing. Check back soon — nothing is being estimated in its place.本面板仍在同步该证券的 SEC 文件，请稍后再查看；此处不作任何估算替代。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前，现金流情景暂不可用。
Capital-need coverage is not available for this issuer yet.该发行人的资本需求覆盖信息暂不可用。
Reported facts remain separate from the cash-flow scenario until identity and filing provenance are confirmed.在确认身份与报告来源之前，已披露事实与现金流情景保持分离。
Research context only — reported figures from SEC filings, not a rating, a signal or investment advice.仅供研究参考 — 数据摘自 SEC 文件披露口径，不构成评级、信号或投资建议。
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Quiet — no confirmed driver平静 — 无明确驱动
Technical技术面
PRGO daily MACD crossed upPRGO 日线MACD上穿
Signal history信号历史
engine events引擎事件
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. A new cycle low likely formed 6 day(s) ago (2026-09-17 @ 13.48): swing low in, price back above the 10-day average — but the weekly timeframe hasn't turned yet, so conviction is partial. Last cycle was left-translated (topped early) — a bearish structural tell买入预备。新的周期低点可能已在 6 天前形成 （2026-09-17 @ 13.48）：摆动低点已现，价格重新站上 10 日均线——但周线周期尚未转向，因此信心仅为部分。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
Sep 25, 2026
PRGO daily MACD crossed upPRGO 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $15.42.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$15.42。
Sep 24, 2026
PRGO took relative-strength leadershipPRGO 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $14.68.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$14.68。
Sep 23, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Sep 22, 2026
PRGO took relative-strength leadershipPRGO 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $14.31.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$14.31。
Sep 22, 2026
PRGO StochRSI turned up from oversoldPRGO StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $14.31.StochRSI重回20上方 — 下行动量趋缓的最早预警。$14.31。
Sep 21, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 9, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Sep 8, 2026
Golden cross on PRGOPRGO 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $14.58.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$14.58。
Sep 8, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Sep 8, 2026
PRGO daily MACD crossed downPRGO 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $14.58.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$14.58。
Showing the last 15 of显示最近15条，共 243 signals条信号
Company profile公司档案
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of...Perrigo Company plc 是一家美国公司在爱尔兰注册的制造商，生产自有品牌非处方药。尽管Perrigo 70%的净销售额来自美国医疗体系，但其出于税务目的合法将总部设在爱尔兰，该地仅占净销售额的0.60%。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Profitability盈利能力
Below market低于市场
Quality质量
Below market低于市场
Investment资本投入
Above market高于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Above market高于市场
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 0.7× | 3.3× | 97% |
| Price / Sales市销率 | 0.5× | 3.2× | 90% |
| Earnings yield盈利收益率 | -67.2% | 2.6% | 2% |
| Free-cash-flow yield自由现金流收益率 | 11.2% | 5.5% | 86% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
7/100 — weaker than most弱于多数
vs market, 3 months相对大盘（3个月）
98/100 — stronger than most强于多数
vs market, 6 months相对大盘（6个月）
93/100 — stronger than most强于多数
vs market, 12 months相对大盘（12个月）
21/100 — weaker than most弱于多数
Rank in sector行业内排名
#156 / 173
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +13.7% | +1.3% |
| 1 Month近1月 | +6.6% | +0.9% |
| 3 Months近3月 | +55.0% | +6.1% |
| 6 Months近6月 | +66.0% | +22.3% |
| Year to date年初至今 | +16.5% | +13.8% |
| 1 Year近1年 | -22.1% | +18.5% |
| 3 Years近3年 | -44.2% | +87.8% |
Trading information交易信息
Beta vs market贝塔
1.09
Volatility rank波动率分位
47th pctile
Short interest空头占比
16.4% of float
Market cap市值
$2B
EPS (trailing)每股收益
$-10.36
Off 52-week high距52周高点
-28.1%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $5.1B | $4.1B | $4.5B | $4.7B | $4.4B | $4.3B |
| EPS每股收益 | $-1.19 | $-0.52 | $-1.04 | $-0.09 | $-1.25 | $-10.29 |
| Free cash flow自由现金流 | $466M | $4M | $211M | $304M | $245M | $145M |
| Gross margin毛利率 | 35.9% | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Net margin净利率 | -3.2% | -1.7% | -3.2% | -0.3% | -3.9% | -33.5% |
| FCF margin自由现金流利润率 | 9.2% | 0.1% | 4.7% | 6.5% | 5.6% | 3.4% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$4.3B
Gross profit毛利润
$1.5B
Net income净利润
$-1.4B
Operating cash flow经营现金流
$238M
Total assets总资产
$8.5B
Shareholder equity股东权益
$2.9B
Long-term debt长期负债
$3.6B
Shares outstanding总股本
0.14B
Returns & growth回报与增长
Return on equity股本回报率
-48.6%
Return on assets资产回报率
-16.7%
Debt / assets负债/资产
42.2%
Asset growth资产增速
-11.5%
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量：盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本：营运资本与销售大致同步
- Pricing power: soft gross profitability vs peers定价能力：毛利能力弱于同业
- Capital discipline: disciplined growth, returning cash资本纪律：增长克制、回报股东
- Balance sheet: Altman Z -0.06 — distress zone资产负债表：Altman Z -0.06——困境区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
68
RSI (2-day)RSI（2日）
91
vs 20-day average相对20日均线
+8.8%
vs 50-day average相对50日均线
+20.2%
vs 200-day average相对200日均线
+28.9%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
above signal位于信号线上方
Timeframe alignment多周期共振
Daily日线
momentum up — fresh upturn动能向上——刚刚转强
3-day3日线
momentum up动能向上
Weekly周线
momentum up动能向上
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
44/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $0.50 | $0.31 | +61.3% |
| Mar 2026 | $0.43 | $0.39 | +10.3% |
| Dec 2025 | $0.77 | $0.80 | -3.8% |
| Sep 2025 | $0.80 | $0.75 | +6.7% |
Estimate revisions预期修正
Analysts covering覆盖分析师
4
Estimate direction预期调整方向
mostly raising多数上调
Estimate change, 90 days预期变化（90天）
+1.5%
Net upgrades, 30 days净上调（30天）
+4
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Insiders & shorts内部人与空头
Short interest空头占流通盘
16.4%
Days to cover回补天数
9.3
Short interest change空头变化
+0.3%
Recent fund flows近期基金流向
SPDR S&P PharmaceuticalsSPDR S&P Pharmaceuticals
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Apr · 67%
Weakest month最弱月份
Oct · 0%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 33% | -0.2% | 3 |
| Feb2月 | 33% | -6.7% | 3 |
| Mar3月 | 33% | -2.1% | 3 |
| Apr4月 | 67% | +1.8% | 3 |
| May5月 | 33% | -3.5% | 3 |
| Jun6月 | 33% | -5.2% | 3 |
| Jul7月 | 67% | 0.0% | 3 |
| Aug8月 | 50% | +4.2% | 4 |
| Sep9月 | 25% | -6.1% | 4 |
| Oct10月 | 0% | -6.9% | 3 |
| Nov11月 | 67% | +11.2% | 3 |
| Dec12月 | 67% | +4.6% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。